List of Excipients in API BUSPIRONE HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing BUSPIRONE HYDROCHLORIDE
Detailed excipient profiles for BUSPIRONE HYDROCHLORIDE
Excipient focus: ANHYDROUS LACTOSE
BUSPIRONE HYDROCHLORIDE drug variants containing ANHYDROUS LACTOSE
BUSPIRONE HYDROCHLORIDE drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CARBOXYMETHYLCELLULOSE
BUSPIRONE HYDROCHLORIDE drug variants containing CARBOXYMETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| EPIC PHARMA LLC | buspirone hydrochloride | 42806-831 |
| PANGEA PHARMACEUTICALS LLC | buspirone hydrochloride | 81279-122 |
| >Company | >Ingredient | >NDC |
BUSPIRONE HYDROCHLORIDE drug variants not containing CARBOXYMETHYLCELLULOSE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
BUSPIRONE HYDROCHLORIDE drug variants containing CELLULOSE, MICROCRYSTALLINE
BUSPIRONE HYDROCHLORIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: COLLOIDAL SILICON DIOXIDE
BUSPIRONE HYDROCHLORIDE drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | buspirone hydrochloride | 16590-579 |
| DirectRX | buspirone hydrochloride | 61919-600 |
| Dispensing Solutions Inc | buspirone hydrochloride | 66336-052 |
| Dispensing Solutions Inc | buspirone hydrochloride | 68258-7087 |
| >Company | >Ingredient | >NDC |
BUSPIRONE HYDROCHLORIDE drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSCARMELLOSE SODIUM
BUSPIRONE HYDROCHLORIDE drug variants containing CROSCARMELLOSE SODIUM
BUSPIRONE HYDROCHLORIDE drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: FD&C YELLOW NO. 6
BUSPIRONE HYDROCHLORIDE drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Quality Care Products LLC | buspirone hydrochloride | 55700-861 |
| REMEDYREPACK INC | buspirone hydrochloride | 70518-2300 |
| REMEDYREPACK INC | buspirone hydrochloride | 70518-2591 |
| Bryant Ranch Prepack | buspirone hydrochloride | 71335-1608 |
| >Company | >Ingredient | >NDC |
BUSPIRONE HYDROCHLORIDE drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
BUSPIRONE HYDROCHLORIDE drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| REMEDYREPACK INC | buspirone hydrochloride | 70518-3939 |
| >Company | >Ingredient | >NDC |
BUSPIRONE HYDROCHLORIDE drug variants not containing FERRIC OXIDE RED
Excipient focus: GELATIN
BUSPIRONE HYDROCHLORIDE drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| EPIC PHARMA LLC | buspirone hydrochloride | 42806-831 |
| PANGEA PHARMACEUTICALS LLC | buspirone hydrochloride | 81279-122 |
| >Company | >Ingredient | >NDC |
BUSPIRONE HYDROCHLORIDE drug variants not containing GELATIN
Excipient focus: LACTOSE MONOHYDRATE
BUSPIRONE HYDROCHLORIDE drug variants containing LACTOSE MONOHYDRATE
BUSPIRONE HYDROCHLORIDE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
BUSPIRONE HYDROCHLORIDE drug variants containing MAGNESIUM STEARATE
BUSPIRONE HYDROCHLORIDE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
BUSPIRONE HYDROCHLORIDE drug variants containing MICROCRYSTALLINE CELLULOSE 102
BUSPIRONE HYDROCHLORIDE drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: POVIDONE
BUSPIRONE HYDROCHLORIDE drug variants containing POVIDONE
BUSPIRONE HYDROCHLORIDE drug variants not containing POVIDONE
Excipient focus: SILICA
BUSPIRONE HYDROCHLORIDE drug variants containing SILICA
BUSPIRONE HYDROCHLORIDE drug variants not containing SILICA
Excipient focus: SILICON DIOXIDE
BUSPIRONE HYDROCHLORIDE drug variants containing SILICON DIOXIDE
BUSPIRONE HYDROCHLORIDE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURYL SULFATE
BUSPIRONE HYDROCHLORIDE drug variants containing SODIUM LAURYL SULFATE
BUSPIRONE HYDROCHLORIDE drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
BUSPIRONE HYDROCHLORIDE drug variants containing SODIUM STARCH GLYCOLATE TYPE A
BUSPIRONE HYDROCHLORIDE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
BUSPIRONE HYDROCHLORIDE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
BUSPIRONE HYDROCHLORIDE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SODIUM STARCH GLYCOLATE TYPE B POTATO
BUSPIRONE HYDROCHLORIDE drug variants containing SODIUM STARCH GLYCOLATE TYPE B POTATO
BUSPIRONE HYDROCHLORIDE drug variants not containing SODIUM STARCH GLYCOLATE TYPE B POTATO
Excipient focus: TITANIUM DIOXIDE
BUSPIRONE HYDROCHLORIDE drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| EPIC PHARMA LLC | buspirone hydrochloride | 42806-831 |
| PANGEA PHARMACEUTICALS LLC | buspirone hydrochloride | 81279-122 |
| >Company | >Ingredient | >NDC |
BUSPIRONE HYDROCHLORIDE drug variants not containing TITANIUM DIOXIDE
Excipient focus: WATER
BUSPIRONE HYDROCHLORIDE drug variants containing WATER
BUSPIRONE HYDROCHLORIDE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch